SUBLOCADE Long-term Outcomes
About the study
This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as measures of participants' physical, psychological, social, and economic well-being will be monitored to better understand factors associated with recovery from opioid use disorder (OUD). Therefore, this study will observe participants up to a maximum of 4 years.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
EXCLUSION CRITERIA
Participants must meet all of the following criteria:
- Is an adult ≥ 18 years of age who has signed the informed consent form
- Plans to receive additional SUBLOCADE injections and
* Has initiated treatment for OUD/opioid dependence with SUBLOCADE within the last 3 months prior to Baseline Visit
- OR
- Has completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and has received the last dose of SUBLOCADE on that study within 3 months prior to Baseline Visit
- Is not currently participating in any clinical trial requiring medical intervention
- Is not currently using opioids to treat a diagnosis other than OUD/opioid dependence
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study Details
Contition
Opioid Use Disorder
Age
18+
Participants Needed
1200
Est. Completion Date
Aug 31, 2027
Treatment Type
OBSERVATIONAL
Sponsor
Indivior Inc.
ClinicalTrials.gov NCT Identifier
NCT05860959
Study Number
INDV-6000-406
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?